354
Views
59
CrossRef citations to date
0
Altmetric
Reviews

Prominin–1 (CD133): from progenitor cells to human diseases

Pages 213-225 | Published online: 18 Jan 2017

Bibliography

  • Fargeas CA, Corbeil D, Huttner WB: AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells 21, 506–508 (2003)
  • Yin AH, Miraglia S, Zanjani ED et al.: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002–5012 (1997).
  • Describes the human prominin-1, initially referred to as AC133 antigen, as a novel antigenic marker of a subpopulation of CD34+ hematopoietic stem and progenitor cells.
  • Weigmann A, Corbeil D, Hellwig A, Huttner WB: Prominin, a novel microvillispecific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of nonepithelial cells. Proc. Natl Acad. Sci. USA 94, 12425–12430 (1997).
  • First description of prominin-1 in murine tissues, including neuroepithelial progenitors and other epithelia. The authors also demonstrated the specific localization of prominin-1 in plasma membrane protrusions.
  • Miraglia S, Godfrey W, Yin AH et al.: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013–5021 (1997).
  • Describes the human prominin-1, initially referred to as AC133 antigen, as a novel antigenic marker of a subpopulation of CD34+ hematopoietic stem and progenitor cells.
  • Röper K, Corbeil D, Huttner WB: Retention of prominin in microvilli reveals distinct cholesterol-based lipid microdomains in the apical plasma membrane. Nature Cell Biol. 2, 582–592 (2000).
  • Demonstrates that prominin-1 binds to plasma membrane cholesterol, and is associated with the membrane lipid microdomain.
  • Corbeil D, Röper K, Fargeas CA, Joester A, Huttner WB: Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2, 82–91 (2001)
  • Shmelkov SV, St Clair R, Lyden D, Rafii S: AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 37, 715–719 (2005)
  • Fargeas CA, Florek M, Huttner WB, Corbeil D: Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J. Biol. Chem. 278, 8586–8596 (2003)
  • Corbeil D, Röper K, Weigmann A, Huttner WB: AC133 hematopoietic stem cell antigen – human homologue of mouse kidney prominin or distinct member of a novel protein family. Blood 91, 2625–2626 (1998)
  • Maw MA, Corbeil D, Koch J et al.: A frameshift mutation in prominin (mouse)- like 1 causes human retinal degeneration. Hum. Mol. Genet. 9, 27–34 (2000).
  • First report of a mutation in the human PROMININ-1 gene that causes a retinal degeneration.
  • Shmelkov SV, Jun L, St Clair R et al.: Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103, 2055–2061 (2004)
  • Miraglia S, Godfrey W, Buck D: A response to AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 91, 4390–4391 (1998)
  • Yu Y, Flint A, Dvorin EL, Bischoff J: AC133–2, a novel isoform of human AC133 stem cell antigen. J. Biol. Chem. 277, 20711–20716 (2002)
  • Jun L, Shmelkov SV, Clair RS et al.: Identification and differential expression of three novel alternatively spliced isoforms of hematopoietic stem cell marker AC133. Blood 102, 330A (2003)
  • Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB, Corbeil D: Identification of novel prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J. Cell Sci. 117, 4301–4311 (2004)
  • Kania G, Corbeil D, Fuchs J et al.: The somatic stem cell marker prominin- 1/CD133 is expressed in embryonic stem cellderived progenitors. Stem Cells 23, 791–804 (2005)
  • Corbeil D, Röper K, Hellwig A et al.: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 275, 5512–5520 (2000)
  • Uchida N, Buck DW, He D et al.: Direct isolation of human central nervous system Stem Cells Proc. Natl Acad. Sci. USA 97, 14720–14725 (2000).
  • First demonstration that prominin-1 (AC133) can be used as a cell surface marker to isolate neural stem cells derived from human fetal brain. These cells are capable of neurophere initiation, selfrenewal, and multilineage differentiation at the single-cell level.
  • Florek M, Haase M, Marzesco A-M et al.: Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 319, 15–26 (2005).
  • Demonstrates that the expression of the human prominin-1 polypeptide is not limited to the stem cell population.
  • Pötgens AJ, Schmitz U, Kaufmann P, Frank HG: Monoclonal antibody CD133–2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokerati 18J. Histochem. Cytochem. 50, 1131–1134 (2002)
  • Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA: Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 98, 10716–10721 (2001)
  • Carpenter MK, Rosler E, Rao MS: Characterization and differentiation of human embryonic stem cells. Cloning and Stem Cells 5, 79–88 (2003)
  • Hoffman LM, Carpenter MK: Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699–708 (2005)
  • Shamblott MJ, Axelman J, Littlefield JW et al.: Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl Acad. Sci. USA 98, 113–118 (2001)
  • Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R: Endothelial cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA. 99, 4391–4396 (2002)
  • Krause DS, Fackler MJ, Civin CI, May WS: CD34: structure, biology, and clinical utility. Blood 87, 1–13 (1996)
  • de Wynter EA, Buck D, Hart C et al.: CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCIDrepopulating cells and dendritic cell progenitors. Stem Cells 16, 387–396 (1998)
  • Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M: Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95, 2813–2820 (2000)
  • Kuci S, Wessels JT, Buhring HJ et al.: Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood 101, 869–876 (2003)
  • Padovan CS, Jahn K, Birnbaum T et al.: Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant. 12, 839–848 (2003)
  • Gehling UM, Ergun S, Schumacher U et al.: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95, 3106–3112 (2000)
  • Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL: Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br. J. Haematol. 115, 186–194 (2001)
  • Torrente Y, Belicchi M, Sampaolesi M et al.: Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114, 182–195 (2004)
  • Gordon PR, Leimig T, Babarin-Dorner A et al.: Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant. 31, 17–22 (2003)
  • Koehl U, Zimmermann S, Esser R et al.: Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant. 29, 927–930 (2002)
  • Lang P, Bader P, Schumm M et al.: Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br. J. Haematol. 124, 72–79 (2004)
  • Bornhäuser M, Eger L, Oelschlaegel U et al.: Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells. Leukemia 19, 161–165 (2005)
  • Tamaki S, Eckert K, He D et al.: Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. 69, 976–986 (2002)
  • Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK, Klassen H: Isolation and characterization of neural progenitor cells from post-mortem human cortex. J. Neurosci. Res. 74, 838–851 (2003)
  • Lee A, Kessler JD, Read T-A et al.: Isolation of neural stem cells from postnatal cerebellum. Nature Neurosci. 8, 723–729 (2005).
  • Demonstrates that prominin-1, as a cell surface marker, can be used to isolate progenitors from the postnatal cerebellum. Identification of cerebellar stem cells has important implications for the understanding of cerebellar development and the origins of medulloblastoma.
  • Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I: Expression of neural stem cell surface marker CD133 in Balloon cells of human focal cortical dysplasia. Epilepsia 46, 1716–1723 (2005)
  • Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L: CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. J. Hematotherapy Stem Cell Res. 10, 273–281 (2001)
  • Alessandri G, Pagano S, Bez A et al.: Isolation and culture of human musclederived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364, 1872–1883 (2004)
  • Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117, 3539–3545 (2004)
  • Bussolati B, Bruno S, Grange C et al.: Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 166, 545–555 (2005)
  • Cantley LG: Adult stem cells in the repair of the injured renal tubule. Nature Clin. Pract. Nephrol. 1, 22–32 (2005)
  • Belicchi M, Pisati F, Lopa R et al.: Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J. Neurosci. Res. 77, 475–486 (2004)
  • Asahara T, Kawamoto A: Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 287, C572–C579 (2005)
  • Peichev M, Naiyer AJ, Pereira D et al.: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95, 952–958 (2000)
  • Agbulut O, Vandervelde S, Al Attar N et al.: Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J. Am. Coll. Cardiol. 44, 458–463 (2004)
  • Pompilio G, Cannata A, Peccatori F et al.: Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann. Thorac. Surg. 78, 1808–1812 (2004)
  • Ghodsizad A, Klein HM, Borowski A et al.: Intraoperative isolation and processing of BM-derived stem cells. Cytotherapy 6, 523–526 (2004)
  • Stamm C, Kleine HD, Westphal B et al.: CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac. Cardiovasc. Surg. 52, 152–158 (2004)
  • Powell TM, Paul JD, Hill JM et al.: Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 25, 296–301 (2005)
  • Schatteman G: Are circulating CD133+ cells biomarkers of vascular disease? Arterioscler. Thromb. Vasc. Biol. 25, 270–271 (2005)
  • Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE: Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol. Ther. 2, 255–256 (2003)
  • Hilbe W, Dirnhofer S, Oberwasserlechner F et al.: CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J. Clin. Pathol. 57, 965–969 (2004)
  • Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3, 730–737 (1997)
  • Waller CF, Martens UM, Lange W: Philadelphia chromosome-positive cells are equally distributed in AC133+ and AC133- fractions of CD34+ peripheral blood progenitor cells from patients with CML. Leukemia 13, 1466–1467 (1999)
  • Baersch G, Baumann M, Ritter J, Jurgens H, Vormoor J: Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia. Br. J. Haematol. 107, 572–580 (1999)
  • Buhring HJ, Seiffert M, Marxer A et al.: AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood 94, 832–833 (1999)
  • Green CL, Loken M, Buck D, Deeg HJ: Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML). Leukemia 14, 770–772 (2000)
  • Bhatia M: AC133 expression in human stem cells. Leukemia 15, 1685–1688 (2001)
  • Horn PA, Tesch H, Staib P, Kube D, Diehl V, Voliotis D: Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood 93, 1435–1437 (1999)
  • Hemmati HD, Nakano I, Lazareff JA et al.: Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA. 100, 15178–15183 (2003)
  • Singh SK, Clarke ID, Terasaki M et al.: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821–5828 (2003)
  • Singh SK, Hawkins C, Clarke ID et al.: Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
  • Demonstrates that prominin-1+ cells, derived from human brain tumor, are capable of tumor initiation in non-obese diabetic, severe combined immunodeficient mouse brains. Thus, prominin-1 might become a cellular target for more effective cancer therapies.
  • Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946–10951 (2005)
  • Rizzo S, Attard G, Hudson DL: Prostate epithelial stem cells. Cell Prolif. 38, 363–374 (2005)
  • Corbeil D, Röper K, Hannah MJ, Hellwig A, Huttner WB: Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - a combination of apical sorting and retention in plasma membrane protrusions. J. Cell Sci. 112, 1023–1033 (1999)
  • Giebel B, Corbeil D, Beckmann J et al.: Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 104, 2332–2338 (2004).
  • Demonstration that prominin-1 (AC133) is concentrated selectively in the uropod structure of migrating hematopoietic stem cells.
  • Rajesndran L, Simons K: Lipid rafts and membrane dynamics. J. Cell Sci. 118, 1099–1102 (2005)
  • Ikonen E: Roles of lipid rafts in membrane transport. Curr. Opin. Cell Biol. 13, 470–477 (2001)
  • Poole K, Meder D, Simons K, Muller D: The effect of raft lipid depletion on microvilli formation in MDCK cells, visualized by atomic force microscopy. FEBS Lett. 565, 53–58 (2004)
  • Iglic A, Hagerstrand H, Veranic P, Plemenitas A, Kralj-Iglic V: Curvatureinduced accumulation of anisotropic membrane components and raft formation in cylindrical membrane protrusions. J. Theor. Biol.
  • Madore N, Smith KL, Graham CH et al.: Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J. 18, 6917–6926 (1999)
  • Drobnik W, Borsukova H, Bottcher A et al.: Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3, 268–278 (2002)
  • Pike LJ: Lipid rafts: heterogeneity on the high seas. Biochem. J. 378, 281–292 (2004)
  • Chamberlain LH: Detergents as tools for the purification and classification of lipid rafts. FEBS Lett. 559, 1–5 (2004)
  • Marzesco A-M, Janich P, Wilsch-Bräuninger M et al.: Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 118, 2849–2858 (2005).
  • First demonstration of a novel class of membrane particles containing prominin-1 that are released into several mammalian body fluids.
  • Huttner WB, Zimmerberg J: Implications of lipid microdomains for membrane curvature, budding and fission. Current Opin. Cell Biol. 13, 478–484 (2001)
  • Lie DC, Colamarino SA, Song HJ et al.: Wnt signalling regulates adult hippocampal neurogenesis. Nature 437, 1370–1375 (2005)
  • Holowka D, Baird B: Fc(epsilon)RI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells. Semin. Immunology 13, 99–105 (2001)
  • Yanagisawa M, Nakamura K, Taga T: Roles of lipid rafts in integrin-dependent adhesion and gp130 signalling pathway in mouse embryonic neural precursor cells. Genes Cells 9, 801–809 (2004)
  • de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M: Lipid raft-associated protein sorting in exosomes. Blood 102, 4336–4344 (2003)
  • Kosodo Y, Röper K, Haubensak W, Marzesco A-M, Corbeil D, Huttner WB: Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J. 23, 2314–2324 (2004)
  • Freund D, Boxberger S, Oswald J et al.: Cells of mesenchymal origin support ex vivo expansion of hematopoietic stem cells. Presented at: European Life Scientist Organization Meeting, Dresden, Germany, 20–24 September 2003 (Abstract)
  • Steinberg RH, Fisher SK, Anderson DH: Disc morphogenesis in vertebrate photoreceptors. J. Comp. Neurol. 190, 501–508 (1980)
  • Michaelides M, Hunt DM, Moore AT: The genetics of inherited macular dystrophies. J. Med. Genet. 40, 641–650 (2003)
  • Oh H, Missol-Kolka E, Moons L et al.: Prominin-1 deficiency leads to progressive retinal degeneration. Presented at: ARVO 2005 Annual Meeting, Fort Lauderdale, Florida, USA, 1–5 May 2005 (Abstract B421).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.